1054 related articles for article (PubMed ID: 9329964)
1. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
2. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
4. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
5. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
7. Basal nitric oxide production is impaired in offspring of patients with essential hypertension.
McAllister AS; Atkinson AB; Johnston GD; Hadden DR; Bell PM; McCance DR
Clin Sci (Lond); 1999 Aug; 97(2):141-7. PubMed ID: 10409468
[TBL] [Abstract][Full Text] [Related]
8. Prolonged local forearm hyperinsulinemia induces sustained enhancement of nitric oxide-dependent vasodilation in healthy subjects.
Hermann TS; Ihlemann N; Dominguez H; Rask-Madsen C; Kober L; Torp-Pedersen C
Endothelium; 2004; 11(5-6):231-9. PubMed ID: 15763942
[TBL] [Abstract][Full Text] [Related]
9. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic sympathectomy on vascular function in the human forearm.
Eisenach JH; Clark ES; Charkoudian N; Dinenno FA; Atkinson JL; Fealey RD; Dietz NM; Joyner MJ
J Appl Physiol (1985); 2002 May; 92(5):2019-25. PubMed ID: 11960953
[TBL] [Abstract][Full Text] [Related]
12. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Woodman RJ; Playford DA; Watts GF
Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.
Kamper AM; de Craen AJ; Westendorp RG; Blauw GJ
Vasc Health Risk Manag; 2005; 1(3):251-6. PubMed ID: 17319111
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
15. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
16. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Hypertension; 1997 Oct; 30(4):918-21. PubMed ID: 9336393
[TBL] [Abstract][Full Text] [Related]
17. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
18. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
[TBL] [Abstract][Full Text] [Related]
19. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
20. Endogenous nitric oxide attenuates beta-adrenoceptor-mediated relaxation in rat aorta.
Kang KB; van der Zypp A; Majewski H
Clin Exp Pharmacol Physiol; 2007; 34(1-2):95-101. PubMed ID: 17201742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
